IL-13Rα1 Suppresses Tumor Progression in Two-Stage Skin Carcinogenesis Model by Regulating Regulatory T Cells

Area of Science:

• Immunology
• Dermatology
• Oncology

Background:

• Type 2 inflammation-related cytokine IL-13 demonstrates a protective role in experimental papilloma induction.
• Understanding the mechanisms of IL-13 in papilloma formation is crucial for skin cancer research.

Purpose of the Study:

• To investigate the role of IL-13 receptor alpha 1 (IL-13Rα1) in chemically induced skin carcinogenesis.
• To elucidate the immunological mechanisms underlying IL-13's protective effect against squamous cell carcinoma development.

Main Methods:

• Utilized Il13rα1-knockout (KO) mice in a 7,12-dimethylbenz[a]anthracene/12-O-tetradecanoyl phorbol-13-acetate two-stage skin carcinogenesis protocol.
• Analyzed papilloma development, regulatory T cell populations, and cytokine levels (IL-2, IL-10, IL-5, TSLP, IL-22) in KO and wild-type mice.
• Assessed polymorphonuclear myeloid-derived suppressor cells during early papilloma induction.

Main Results:

• KO mice developed significantly more papillomas and at a faster rate compared to wild-type mice.
• Papilloma development led to reduced regulatory T cells and decreased IL-2/IL-10 levels in wild-type mice, but not in KO mice.
• Elevated systemic IL-5 and TSLP, and decreased IL-22 were observed in KO mice during papilloma formation. Polymorphonuclear myeloid-derived suppressor cells were reduced in KO mice early on.

Conclusions:

• IL-13Rα1 is essential for protection against chemically induced skin papilloma development.
• Functional IL-4 and IL-13 signaling through the type II IL-4 receptor plays a significant role in regulating tumor development in skin carcinogenesis.